Benzinga - Mon, 08 Feb 2021 13:45:56 -0400
Benzinga - Fri, 29 Jan 2021 08:45:43 -0400
Benzinga - Thu, 28 Jan 2021 23:31:27 -0400
Benzinga - Thu, 28 Jan 2021 17:35:43 -0400
Benzinga - Thu, 28 Jan 2021 17:03:35 -0400
Benzinga - Fri, 22 Jan 2021 13:32:54 -0400
Benzinga - Fri, 22 Jan 2021 11:05:42 -0400
Benzinga - Fri, 22 Jan 2021 11:03:51 -0400
Benzinga - Fri, 22 Jan 2021 08:49:56 -0400
Benzinga - Fri, 22 Jan 2021 08:41:43 -0400
Benzinga - Fri, 22 Jan 2021 08:22:33 -0400
Benzinga - Thu, 21 Jan 2021 13:21:54 -0400
Benzinga - Thu, 21 Jan 2021 11:12:45 -0400
Benzinga - Thu, 21 Jan 2021 09:05:24 -0400
Benzinga - Wed, 20 Jan 2021 11:15:12 -0400
load more
Sector: Health Care.Industry: Health Care Equipment & Supplies
Neuronetics Inc is a commercial stage medical technology company. It is focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. The company's product the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. Geographically, it generates a majority of its revenue from the United States.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-04
REV
Q4 2020Est.ActualSurprise
EPS-0.240

(EXPECTED) 2021-03-02

REV14.400M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
STIMNeuronetics-11.8%385.3M

Neuronetics Company Questions & Answers

Q

How do I buy Neuronetics (STIM) stock?

A

You can purchase shares of Neuronetics (NASDAQ: STIM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Neuronetics's (STIM) main competitors?

A

Other companies in Neuronetics’s space includes: Oxford Immunotec Global (NASDAQ:OXFD), PAVmed (NASDAQ:PAVM) and Soliton (NASDAQ:SOLY).

Q

What is the target price for Neuronetics?

A

The latest price target for Neuronetics (NASDAQ: STIM) was reported by William Blair on 2021-01-22. The analyst firm set a price target for 0.00 expecting STIM to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.

Q

How much is Neuronetics (STIM) stock ?

A

The stock price for Neuronetics (NASDAQ: STIM) is $15.7 last updated Thu Feb 25 2021 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Neuronetics (STIM) dividend?

A

There are no upcoming dividends for Neuronetics.

Q

When is Neuronetics (NASDAQ:STIM) reporting earnings?

A
Neuronetics’s Q1 earnings are confirmed after-market from now on May 4, 2021.
Q

When is the upcoming split for STIM?

A

There is no upcoming split for Neuronetics.